Indivior Pharmaceuticals (INDV) Financials: Revenue & Earnings
INDV$34.22-0.51 -1.45%
$4.27B
Market Cap
12.17
P/E
8.10
Forward P/E
69
Score
Indivior Pharmaceuticals (INDV) Financials: Revenue & Earnings
INDV price $34.22 -0.51 -1.45%
- Ticker
- INDV
- Price
- $34.22
- Change
- -0.51 -1.45%
- Market cap ?
- $4.27B
- P/E ?
- 12.17
- Forward P/E ?
- 8.10
- Dividend yield ?
- 0.00%
- Beta ?
- 1.11
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stocklytics score
- 69
- Value
- 55
- Quality
- 72
- Growth
- 80
Stocklytics score rationale: value 55, quality 72, growth 80.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 968885463 | 1148105410 | 959924667 | 785000000 | 647000000 | 791000000 | 901000000 | 1093000000 | 1188000000 | 1239000000 |
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United…
Fair value
INDV fair value $63.63. Price $34.22. Price is 46% below fair value.
Above fair value, and more expensive than usual. A larger premium than on 87% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 338.17M. Growth 7.51%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.42% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 124.77M. Net debt 156.00M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | 1.06 | — | 329.35M |
| 2026-08-03 | 1.15 | 0.87 | 343.00M | 306.23M |
| 2026-04-30 | 0.96 | 0.64 | 317.00M | 272.84M |
| 2026-02-26 | 0.82 | 0.65 | 358.00M | 305.62M |
| 2025-10-30 | 0.72 | 0.38 | 314.00M | 306.22M |
| 2025-07-31 | 0.51 | 0.26 | 302.00M | 255.23M |
| 2025-04-24 | 0.41 | 0.22 | 266.00M | 242.30M |
| 2025-02-20 | 0.32 | 0.32 | 299.00M | 240.13M |
| 2024-10-24 | 0.54 | 0.31 | 307.00M | 260.43M |
| 2024-07-25 | 0.44 | 0.40 | 299.61M | 289.37M |
| 2024-04-25 | 0.37 | 0.42 | 282.74M | 299.75M |
| 2024-02-22 | 0.43 | 0.28 | 300.65M | 276.00M |
| 2023-11-09 | 0.34 | 0.30 | 261.20M | 270.50M |
| 2023-07-27 | 0.39 | 0.22 | 279.85M | 255.00M |
| 2023-04-27 | 0.40 | — | 256.80M | 302.67M |
| 2023-02-16 | 0.27 | — | 241.00M | 223.00M |
| 2022-10-27 | 0.29 | — | 232.00M | 217.00M |
| 2022-07-28 | 0.30 | — | 221.00M | 219.00M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency Irregular.
Safety score 49/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividends were paid in 3 separate years. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-11-03 | $8.13 | 2026-10-30 | 2026-11-06 | Irregular |
| 2016-06-16 | $0.47 | 2016-06-17 | 2016-07-29 | Semi-Annual |
| 2015-09-17 | $0.16 | 2015-09-18 | 2015-10-23 | Irregular |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2028-06-02 | Barry Patrick A | Other | 130.31K | — | — |
| 2028-05-08 | Ciaffoni Joseph | Other | 422.30K | — | — |
| 2028-03-07 | Preblick Ryan | Other | 70.46K | — | — |
| 2028-03-07 | Heidbreder Christian | Other | 82.29K | — | — |
| 2028-03-07 | Burris Jeffrey W | Other | 71.74K | — | — |
| 2028-03-07 | Anderson Woodrow D | Other | 29.48K | — | — |
| 2026-08-27 | Anderson Woodrow D | Buy | 1.50K | $35.69 | 53.53K |
| 2026-08-05 | Anderson Woodrow D | Buy | 1.50K | $36.28 | 54.42K |
| 2026-07-10 | Heidbreder Christian | Sell | 18.59K | $41.14 | 764.63K |
| 2026-06-22 | Ciaffoni Joseph | Buy | 1.27M | — | — |
| 2026-06-22 | Ciaffoni Joseph | Sell | 612.55K | $38.32 | 23.47M |
| 2026-06-22 | Ciaffoni Joseph | Sell | 1.27M | — | — |
| 2026-06-11 | Heidbreder Christian | Sell | 18.59K | $38.06 | 707.38K |
| 2026-06-08 | Preblick Ryan | Sell | 36.00K | $37.70 | 1.36M |
| 2026-05-13 | Thompson Juliet | Buy | 6.52K | — | — |
| 2026-05-13 | Humphreys Keith | Buy | 6.52K | — | — |
| 2026-05-13 | Kingsley Stuart A | Buy | 6.52K | — | — |
| 2026-05-13 | NINIVAGGI DANIEL A | Buy | 6.52K | — | — |
| 2026-05-13 | Ryan Barbara | Buy | 6.52K | — | — |
| 2026-05-13 | Stejbach Mark | Buy | 6.52K | — | — |
| 2026-05-13 | Wheadon David E. | Buy | 10.43K | — | — |
| 2026-05-12 | Thompson Juliet | Sell | 1.12K | $38.28 | 42.76K |
| 2026-03-14 | Preblick Ryan | Buy | 6.30K | — | — |
| 2026-03-14 | Preblick Ryan | Sell | 2.84K | $31.11 | 88.45K |
| 2026-03-14 | Preblick Ryan | Sell | 6.30K | — | — |
| 2026-03-13 | Ryan Barbara | Buy | 8 | $31.09 | 249 |
| 2026-03-09 | Ryan Barbara | Buy | 31 | $32.56 | 1.01K |
| 2026-03-06 | Kingsley Stuart A | Buy | 940 | $31.86 | 29.95K |
| 2026-03-03 | Anderson Woodrow D | Buy | 18.36K | — | — |
| 2026-03-03 | Anderson Woodrow D | Buy | 5.95K | — | — |
| 2026-03-03 | Anderson Woodrow D | Sell | 2.68K | $31.98 | 85.77K |
| 2026-03-03 | Anderson Woodrow D | Sell | 8.28K | $31.98 | 264.89K |
| 2026-03-03 | Anderson Woodrow D | Sell | 23.98K | — | — |
| 2026-03-03 | Anderson Woodrow D | Sell | 5.95K | — | — |
| 2026-03-03 | Preblick Ryan | Buy | 86.95K | — | — |
| 2026-03-03 | Preblick Ryan | Sell | 87.60K | $31.98 | 2.80M |
| 2026-03-03 | Preblick Ryan | Sell | 113.51K | — | — |
| 2026-03-03 | Burris Jeffrey W | Buy | 79.89K | — | — |
| 2026-03-03 | Burris Jeffrey W | Sell | 36.03K | $31.98 | 1.15M |
| 2026-03-03 | Burris Jeffrey W | Sell | 104.30K | — | — |
| 2026-03-03 | Heidbreder Christian | Buy | 101.54K | — | — |
| 2026-03-03 | Heidbreder Christian | Sell | 45.80K | $31.98 | 1.46M |
| 2026-03-03 | Heidbreder Christian | Sell | 132.56K | — | — |
| 2026-02-10 | Anderson Woodrow D | Buy | 6.90K | — | — |
| 2026-02-10 | Preblick Ryan | Buy | 37.36K | — | — |
| 2026-02-10 | Burris Jeffrey W | Buy | 26.90K | — | — |
| 2026-02-10 | Heidbreder Christian | Buy | 33.62K | — | — |
| 2026-02-10 | Barry Patrick A | Buy | 31.38K | — | — |
| 2026-02-10 | Ciaffoni Joseph | Buy | 79.98K | — | — |
| 2026-02-09 | Anderson Woodrow D | Buy | 23.98K | — | — |
| 2026-02-09 | Preblick Ryan | Buy | 113.51K | — | — |
| 2026-02-09 | Burris Jeffrey W | Buy | 104.30K | — | — |
| 2026-02-09 | Heidbreder Christian | Buy | 132.56K | — | — |
| 2026-01-26 | Kingsley Stuart A | Buy | 3.72K | — | — |
| 2026-01-26 | Wheadon David E. | Buy | 5.96K | — | — |
| 2026-01-26 | Ryan Barbara | Buy | 3.72K | — | — |
| 2026-01-26 | NINIVAGGI DANIEL A | Buy | 3.72K | — | — |
| 2026-01-26 | Stejbach Mark | Buy | 3.72K | — | — |
| 2026-01-26 | Thompson Juliet | Buy | 3.72K | — | — |
| 2026-01-26 | Humphreys Keith | Buy | 3.72K | — | — |
| 2026-01-05 | Ryan Barbara | Buy | 775 | $35.39 | 27.43K |
| 2026-01-05 | Humphreys Keith | Buy | 775 | $35.39 | 27.43K |
| 2026-01-05 | NINIVAGGI DANIEL A | Buy | 775 | $35.39 | 27.43K |
| 2026-01-05 | Stejbach Mark | Buy | 775 | $35.39 | 27.43K |
| 2026-01-05 | Wheadon David E. | Buy | 1.77K | $35.39 | 62.68K |
| 2026-01-01 | Ryan Barbara | Other | 0 | — | — |
| 2026-01-01 | NINIVAGGI DANIEL A | Other | 0 | — | — |
| 2026-01-01 | Kingsley Stuart A | Other | 0 | — | — |
| 2026-01-01 | Thompson Juliet | Other | 0 | — | — |
| 2026-01-01 | Thompson Juliet | Other | 0 | — | — |
| 2026-01-01 | Stejbach Mark | Other | 0 | — | — |
| 2026-01-01 | Ciaffoni Joseph | Other | 0 | — | — |
| 2026-01-01 | Ciaffoni Joseph | Other | 1.27M | — | — |
| 2026-01-01 | Wheadon David E. | Other | 0 | — | — |
| 2026-01-01 | Preblick Ryan | Other | 0 | — | — |
| 2026-01-01 | Humphreys Keith | Other | 0 | — | — |
| 2026-01-01 | Heidbreder Christian | Other | 0 | — | — |
| 2026-01-01 | Burris Jeffrey W | Other | 0 | — | — |
| 2026-01-01 | Anderson Woodrow D | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 348, holders +51 vs prior quarter. Ownership 97.83%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 18.71M | 167.21K | +0.90% | 767.65M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.57M | -319.53K | -4.05% | 310.69M |
| OAKTREE CAPITAL MANAGEMENT LP | 6.13M | -856.89K | -12.27% | 251.40M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.50M | -91.09K | -1.63% | 225.48M |
| STATE STREET CORP | 4.99M | 88.08K | +1.80% | 204.82M |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4.62M | 86.23K | +1.90% | 189.39M |
| TWO SEAS CAPITAL LP | 3.48M | -1.27M | -26.69% | 142.76M |
| MORGAN STANLEY | 3.40M | -110.11K | -3.14% | 139.33M |
| FRANKLIN TEMPLETON INC | 3.32M | 3.20M | +2871.83% | 136.07M |
| GEODE CAPITAL MANAGEMENT, LLC | 3.16M | 234.18K | +8.00% | 129.68M |
| MADISON AVENUE PARTNERS, LP | 2.87M | -1.44M | -33.39% | 117.94M |
| MANGROVE PARTNERS IM, LLC | 2.68M | -65.70K | -2.40% | 109.83M |
| CITADEL ADVISORS LLC | 2.67M | -906.22K | -25.36% | 109.46M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2.30M | 419.01K | +22.29% | 94.33M |
| MILLENNIUM MANAGEMENT LLC | 2.10M | -2.50M | -54.33% | 86.12M |
| DIMENSIONAL FUND ADVISORS LP | 1.90M | 564.48K | +42.37% | 77.82M |
| INVESCO LTD. | 1.84M | 281.22K | +18.01% | 75.62M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.65M | -1.45M | -46.77% | 67.65M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.64M | -681.18K | -29.32% | 67.37M |
| ASSENAGON ASSET MANAGEMENT S.A. | 1.54M | 1.54M | New | 63.22M |
| FEDERATED HERMES, INC. | 1.47M | 251.03K | +20.61% | 60.26M |
| JANE STREET GROUP, LLC | 1.36M | 1.36M | New | 55.67M |
| NEWTYN MANAGEMENT, LLC | 1.31M | -694.21K | -34.71% | 53.58M |
| POINT72 ASSET MANAGEMENT, L.P. | 1.25M | 1.16M | +1217.25% | 51.31M |
| NORTHERN TRUST CORP | 1.24M | 80.37K | +6.92% | 50.95M |
Earnings and financials
Indivior Pharmaceuticals Inc (INDV) trades at $34.22, with a market cap of $4.27B and a trailing P/E of 12.17. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 968885463 | 1148105410 | 959924667 | 785000000 | 647000000 | 791000000 | 901000000 | 1093000000 | 1188000000 | 1239000000 |
Insights · Dividends · Forecast · Financials · Learn